Search Results 1791-1800 of 21510 for platelets

1. Publications - Ali J. Ainsworth, M.D. - Mayo Clinic

   Monoclonal Anti-Platelet Factor 4 Antibodies in Recurrent Pregnancy Loss. N Engl J Med 2025 Jul 17; 393 (3):306-309. View PubMed; Lee S, Kendall Rauchfuss LM ...

2. A Study to Evaluate the Immune Response of Healthy Individuals for the 2017-2018 Seasonal Flu Vaccine - Mayo Clinic

   anticoagulant therapy (not including anti-platelet drugs such as aspirin and clopidogrel) that would contraindicate intramuscular injection. Subject has had ...

3. Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

   Platelets ≥ 100,000/mm3. Renal function: Creatinine ≤ 1.5mg/dl. Hepatic function: Bilirubin ≤ 1.5 times ULN;; ALT ≤ 3 times the ULN;; AST ≤ 3 times the ...

4. Study of HPN536 in Patients with Advanced Cancers Associated With Mesothelin Expression - Mayo Clinic

   Platelets ≥ 100,000/mm3 or ≥ 100 x 10^9/L;; Hemoglobin (Hgb) ≥ 0 g/dL. Adequate renal function, including estimated creatinine clearance ≥ 50 mL/min ...

5. A Study To Assess Omega-3 Replacement With Krill Oil In Disease Management Of System Lupus Erythematosus (SLE) - Mayo Clinic

   Platelets: <50,000/mm;; ANC < 1.0 x 103/mm;; AST or ALT >2.5 x Upper Limit of Normal unless related to primary disease;; Creatinine clearance ≤ 25ml/min per ...

6. Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma - Mayo Clinic

   Untransfused platelet count ≥ 75000/uL; Hemoglobin ≥ 8 g/dL; Total bilirubin ≤ 1.5 times institutional upper limit of normal (ULN); Patients with relapsed ...

7. A Study of Disulfiram and Chemotherapy in Pancreas Cancer Patients - Mayo Clinic

   Platelet ≥ 100,000/mm^3;; Total bilirubin ≤ 2 x upper limit of normal (ULN);; AST (SGOT) ≤ 3 x ULN;; Creatinine ≥ 1.5 x ULN;; Hemoglobin ≥ 9.0 g/dL. Cohort ...

8. A Multicenter Study To Evaluate The Efficacy And Safety Of Cinryze® For The Treatment Of Acute Antibody-mediated Rejection In Patients With Kidney Transplant - Mayo Clinic

   Within 72 hours prior to subject dosing platelet count < 25×10^9/L or >600×10^9/L. Be pregnant or breastfeeding. Have received any of the following agents ...

9. Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments - Mayo Clinic

   Platelets > 100,000/mm^3;; Hemoglobin > 9 g/dL;; Creatinine concentration ≤ 1.4 mg/dL, or creatinine clearance > 40 mL/min;; Total bilirubin < 1.5 mg/dL, ALT+ ...

10. Study Evaluating the Antitumor Activity and Safety of Niraparib as Neoadjuvant Treatment - Mayo Clinic

    Platelets ≥100,000/μL;; Hemoglobin ≥9 g/dL;; Serum creatinine ≤1.5 x upper limit of normal (ULN) or calculated creatinine clearance ≥50 mL/min using ...